Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01439802 · ClinicalTrials.gov registry record · Phase 4
Copper Intrauterine Device (IUD) Insertion at Cesarean Delivery
A Phase 4 study of Intrauterine Device Expulsion, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
- 2
- Study locations
NCT01439802 is a Phase 4 study of Intrauterine Device Expulsion that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 90 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT01439802, a Phase 4 study of Intrauterine Device Expulsion, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine the expulsion rates of copper Intrauterine Devices (IUDs) placed at time of Cesarean Delivery.
Conditions Studied
Interventions
- DEVICE Copper IUD placement at time Cesarean Delivery (Copper T 380A)
Study Locations (2)
New York
- Jacobi Medical Center - The Bronx
- Montefiore Medical Center, Weiler Division - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01439802
The ClinicalTrials.gov registry entry for NCT01439802 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intrauterine Device Expulsion appearing as the primary indexed condition, and to 1 intervention - of which Copper IUD placement at time Cesarean Delivery (Copper T 380A) is the first listed.
NCT01439802 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01439802 about?
NCT01439802 is a clinical study titled "Copper Intrauterine Device (IUD) Insertion at Cesarean Delivery". The purpose of this study is to determine the expulsion rates of copper Intrauterine Devices (IUDs) placed at time of Cesarean Delivery.
What is the current status of trial NCT01439802?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2008-08. Estimated completion is 2010-05.
What conditions does trial NCT01439802 study?
This clinical trial studies the following conditions: Intrauterine Device Expulsion.
What interventions are being tested in trial NCT01439802?
The interventions under investigation include: Copper IUD placement at time Cesarean Delivery (Copper T 380A) (DEVICE).
Who is sponsoring clinical trial NCT01439802?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01439802 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.